FLUOROURACIL
5 FLUOROPYRIMIDINES · METASTATIC COLORECTAL CANCER ·+4
EUGIA US LLC
Drug class
5 Fluoropyrimidines
The 5-fluoropyrimidines (commonly referred to as fluoropyrimidines) are a class of antineoplastic antimetabolite drugs, primarily comprising 5-fluorouracil and its oral prodrugs such as capecitabine. Read more about 5 Fluoropyrimidines
34 drugs in this class 34 manufacturers
Drugs in 5 Fluoropyrimidines
CAPECITABINE
5 FLUOROPYRIMIDINES · MALIGNANT ESOPHAGEAL NEOPLASM ·+7
AREVA PHARMACEU
FLUOROURACIL
5 FLUOROPYRIMIDINES · METASTATIC COLORECTAL CANCER ·+4
ALEMBIC PHARMAC
CAPECITABINE
5 FLUOROPYRIMIDINES · MALIGNANT ESOPHAGEAL NEOPLASM ·+7
AHP
CAPECITABINE
5 FLUOROPYRIMIDINES · MALIGNANT ESOPHAGEAL NEOPLASM ·+7
SUN PHARMACEUTI
CAPECITABINE
5 FLUOROPYRIMIDINES · MALIGNANT ESOPHAGEAL NEOPLASM ·+7
LIFESTAR PHARMA
FLUOROURACIL
5 FLUOROPYRIMIDINES · METASTATIC COLORECTAL CANCER ·+4
MEITHEAL PHARMA
FLOXURIDINE
5 FLUOROPYRIMIDINES · MALIGNANT NEOPLASM OF LIVER ·+1
JND THERAPEUTIC
CAPECITABINE
5 FLUOROPYRIMIDINES · MALIGNANT ESOPHAGEAL NEOPLASM ·+7
QUALLENT PHARMA
Filter & compare in the drug finder →
Opens the drug finder with 5 Fluoropyrimidines preselected. Add indication or manufacturer filters there.
The 5-fluoropyrimidines (commonly referred to as fluoropyrimidines) are a class of antineoplastic antimetabolite drugs, primarily comprising 5-fluorouracil and its oral prodrugs such as capecitabine.
They exert their therapeutic anticancer effect predominantly by inhibiting thymidylate synthase and misincorporating fraudulent fluorinated metabolites into RNA and DNA, thereby disrupting nucleic acid synthesis and triggering cell death.
In clinical oncology, this class serves as a foundational therapeutic backbone for treating various solid tumors, most notably gastrointestinal malignancies including colorectal, gastric, and pancreatic cancers, as well as breast cancer and select hyperproliferative skin conditions.
-
fda.gov
The 5-fluoropyrimidines (commonly referred to as fluoropyrimidines) are a class of antineoplastic antimetabolite drugs, primarily comprising 5-fluorouracil and its oral prodrugs such as capecitabine In clinical oncology, this class serves as a foundational therapeutic backbone for treating various solid tumors, most notably gastrointestinal malignancies including colorectal, gastric, and pancreatic cancers, as well as breast cancer and select hyperproliferative skin conditions
-
cancer.gov
The 5-fluoropyrimidines (commonly referred to as fluoropyrimidines) are a class of antineoplastic antimetabolite drugs, primarily comprising 5-fluorouracil and its oral prodrugs such as capecitabine
-
cancer.gov
They exert their therapeutic anticancer effect predominantly by inhibiting thymidylate synthase and misincorporating fraudulent fluorinated metabolites into RNA and DNA, thereby disrupting nucleic acid synthesis and triggering cell death
-
nih.gov
They exert their therapeutic anticancer effect predominantly by inhibiting thymidylate synthase and misincorporating fraudulent fluorinated metabolites into RNA and DNA, thereby disrupting nucleic acid synthesis and triggering cell death
-
mydruggenome.org
In clinical oncology, this class serves as a foundational therapeutic backbone for treating various solid tumors, most notably gastrointestinal malignancies including colorectal, gastric, and pancreatic cancers, as well as breast cancer and select hyperproliferative skin conditions
-
nih.gov
In clinical oncology, this class serves as a foundational therapeutic backbone for treating various solid tumors, most notably gastrointestinal malignancies including colorectal, gastric, and pancreatic cancers, as well as breast cancer and select hyperproliferative skin conditions
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.